lurasidone hydrochloride (Sichuan Kelun Pharmaceutical)

N/A

Report date: 2025/10/28 17:50:38

Base Information

Drug Namelurasidone hydrochloride (Sichuan Kelun Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonistsAlpha-2c adrenergic receptor antagonists +[5] 
TargetsSerotonin 7 (5-HT7) receptorAlpha-2c adrenergic receptorSerotonin 1a (5-HT1a) receptor +[5] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSichuan Kelun Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Kelun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A